【活動快訊】Aaron Ciechanover 教授(2004諾貝爾化學獎得主)醫藥通俗演講

Aaron-Ciechanover222

以色列教授 Aaron Ciechanover (2004諾貝爾化學獎)應王光燦基金會邀請,將於11月6日(星期五)拜訪臺灣大學,下午3:30在化學系松柏講堂做通俗科學演講。

講題:The Revolution of Personalized Medicine: Are We Going to Cure All Diseases and at What Price?

Prof. Aaron Ciechanover

  • Born October 1, 1947.66218-01
  • The Nobel Prize in Chemistry 2004 was awarded jointly to Aaron Ciechanover, Avram Hershko and Irwin Rose "for the discovery of ubiquitin-mediated protein degradation". The ubiquitin-proteasome pathway has a critical role in maintaining the homeostasis of cells and is believed to be involved in the development and progression of diseases such as: cancer, muscular and neurological diseases, immune and inflammatory responses.
  • 2015 王光燦生物有機化學講座

Biography

He received his doctorate in biochemistry in 1981 from the Technion – Israel Institute of Technology in Haifa before conducting postdoctoral research in the laboratory of Harvey Lodish at the Whitehead Institute at MIT from 1981-1984. He is currently a Technion Distinguished Research Professor in the Ruth and Bruce Rappaport Faculty of Medicine and Research Institute at the Technion.

Awards

  • Albert Lasker Award for Basic Medical Research, 2000.
  • Israel Prize, for Biology, 2003.
  • Nobel Prize in Chemistry, 2004.
  • Sir Hans Krebs Medal, 2006.

Member of Scientific Advisory Boards

  • Rosetta Genomics (Chairman)
  • BioLineRx, Ltd
  • StemRad, Ltd
  • Allosterix Ltd
  • Proteologics, Inc
  • MultiGene Vascular Systems, Ltd
  • Protalix BioTherapeutics
  • BioTheryX, Inc.
  • Patient Innovation, a nonprofit, international, multilingual, free venue for patients and caregivers of any disease to share their innovations.

151021-66218-03-711x1024

 

加入好友

1,995 人瀏覽過

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *

為了避免你是機器人,請在留言前回答以下問題: